China Strategic Technology Group Limited released unaudited operating data for August 2026, indicating that monthly revenue fell to RMB 52.27 million, a year-on-year contraction of 70.97% from RMB 180.07 million in August 2025.
The Group’s business portfolio spans aerospace, precision manufacturing, new-energy vessels and biotechnology:
• CT Aerospace – titanium alloy materials, satellite components, digital satellite applications and small unmanned spacecraft. • CT Precision Manufacturing – electronic manufacturing services, printed circuit board assemblies, energy and thermal management systems, intelligent control systems and industrial sensors. • CT Vessel – development and production of new-energy small commercial and civilian vessels integrating aerospace technology and energy-storage know-how. • CT Biotechnology – research and application of life-science and biomedical technologies.
Management highlights the Group’s strategy of leveraging cross-sector synergies among aerospace, intelligent manufacturing, shipbuilding and biotechnology to support long-term diversification and growth.
The disclosed figures are preliminary and unaudited; final results may differ after completion of statutory reviews. Shareholders and potential investors are advised to interpret the data with caution and, when necessary, seek professional advice before making investment decisions.
Comments